International Clinical Trial: A Single-Arm Clinical Trial Study to Evaluate the Efficacy and Safety of Vitamin K2 in Combination with an Immune Checkpoint Inhibitor for the neoadjuvant therapy of Lung Cancer

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119560) titled 'A Single-Arm Clinical Trial Study to Evaluate the Efficacy and Safety of Vitamin K2 in Combination with an Immune Checkpoint Inhibitor for the neoadjuvant therapy of Lung Cancer' on Feb. 28.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The Second Affiliated Hospital, Zhejiang University College of Medicine

Condition: Lung Cancer

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-08-01

Target Sample Size: Experimental Group :43;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=282538

Published by HT...